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Introduction
Lysosome-related organelles (LROs) comprise a class of cell 
type–specific subcellular membranous compartments that derive 
from the endocytic pathway but fulfill diverse physiological 
functions (Dell’Angelica et al., 2000; Raposo et al., 2007; Marks 
et al., 2013). Although some LROs are modified lysosomes, 
others—such as pigment cell melanosomes and platelet dense 
granules—are discrete structures that coexist with endolysosomes 
and are thus generated within their host cells by specialized 
pathways (Raposo et al., 2007; Sitaram and Marks, 2012; Marks 
et al., 2013). Defects in such pathways underlie heritable diseases 
such as Hermansky–Pudlak syndrome (HPS), characterized by 
oculocutaneous albinism, excessive bleeding, and various other 
symptoms as a result of malformation of melanosomes, dense 
granules, and other LROs, respectively (Huizing et al., 2008; 
Wei and Li, 2013). The affected genes in the nine known forms 
of HPS encode subunits of four protein complexes—adaptor 
protein-3 (AP-3) and biogenesis of LROs complex (BLOC)-1, -2, 
and -3 (Dell’Angelica, 2004; Marks et al., 2013; Wei and Li, 
2013). How these complexes function in LRO biogenesis is 
only partially known.
Hermansky–Pudlak syndrome (HPS) is a group of disorders characterized by the malformation of lysosome-related organelles, such as pigment cell 
melanosomes. Three of nine characterized HPS subtypes 
result from mutations in subunits of BLOC-2, a protein 
complex with no known molecular function. In this paper, 
we exploit melanocytes from mouse HPS models to place 
BLOC-2 within a cargo transport pathway from recy-
cling endosomal domains to maturing melanosomes. In 
BLOC-2–deficient melanocytes, the melanosomal protein 
TYRP1 was largely depleted from pigment granules and 
underwent accelerated recycling from endosomes to the 
plasma membrane and to the Golgi. By live-cell imaging, 
recycling endosomal tubules of wild-type melanocytes 
made frequent and prolonged contacts with maturing 
melanosomes; in contrast, tubules from BLOC-2–deficient 
cells were shorter in length and made fewer, more tran-
sient contacts with melanosomes. These results support 
a model in which BLOC-2 functions to direct recycling 
endosomal tubular transport intermediates to maturing 
melanosomes and thereby promote cargo delivery and 
optimal pigmentation.
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to place BLOC-2 function at a late stage of cargo delivery in 
the BLOC-1–dependent transport pathway. Our data show that 
BLOC-2 directs the tubular transport intermediates to interact 
specifically with maturing melanosomes either by “tethering” or 
by stabilizing the transport intermediates.
Results
Hypopigmentation in BLOC-2–deficient 
melanocytes and rescue by missing  
subunit expression
To identify the cargo transport pathway in which BLOC-2 func-
tions, we first sought to define how loss of BLOC-2 expression 
influences melanosome cargo distribution and dynamics. We ex-
ploited immortalized melan-coa melanocytes (heretofore referred 
to as BLOC-2; Suzuki et al., 2001) derived from C57BL/ 
6-Hps3coa/coa (cocoa) mice in which an inactivating mutation in 
Hps3 concomitantly destabilizes HPS5 and HPS6 (Gautam et al., 
2004). By bright-field microscopy, BLOC-2 cells were hypo-
pigmented relative to wild-type (WT) C57BL/6-derived melan-
Ink4a melanocytes (Sviderskaya et al., 2002) but heterogeneous; 
some cells (20%) harbored many lightly pigmented granules 
throughout the cytoplasm, most cells (70%) contained few 
scattered granules (Fig. 1 a), and some (10% at early passages) 
lacked pigment granules altogether. The relative fraction of each 
pigmentation type varied with culture conditions. Similarly, het-
erogeneous but low levels of pigmentation were observed in im-
mortalized melan-ru (Fig. S1 d) and melan-ru2 melanocytes (not 
depicted) derived from BLOC-2–deficient ruby eye (Hps6ru) and 
ruby eye 2 (Hps5ru2) mice. Pigmentation and HPS6 expression 
in BLOC-2 cells were restored to WT levels by stable expres-
sion of human HPS3 (melan-coa:hHPS3 or BLOC-2R), but not of 
the HA-tagged irrelevant BLOC-1 subunit, Muted-HA (MuHA; 
melan-coa:MuHA or BLOC-2C for negative control; Fig. 1, b–d). 
Electron microscopy analysis showed that compared with “res-
cued” BLOC-2R, BLOC-2 cells harbored fewer fully pigmented 
stage IV melanosomes that were unusually rounded, and more 
striated nonpigmented stage II and partially pigmented stage III 
melanosomes with irregular melanin deposits (Fig. 1, e and f), 
consistent with published results (Suzuki et al., 2001). These data 
show that melanosome maturation beyond stage II is impaired in 
the absence of BLOC-2. Except where indicated, the remaining 
experiments compare nonclonal populations of BLOC-2 and/or 
BLOC-2C cells to BLOC-2R or WT melanocytes.
Melanosomal proteins are partially 
mislocalized to endosomes and the Golgi  
in BLOC-2–deficient melanocytes
In BLOC-1–deficient (BLOC-1) melanocytes or human mela-
noma cells depleted of KIF13A or AP-1, melanosomal cargoes 
such as TYRP1 accumulate in enlarged early endosomes as a 
result of failed extraction from endosomes toward melanosomes 
and consequent increased endosomal recycling (Setty et al., 
2007; Delevoye et al., 2009). To define cargo mislocalization 
in BLOC-2–deficient melanocytes, we first used deconvolu-
tion immunofluorescence microscopy (IFM) to assess localiza-
tion of TYRP1 relative to early sorting and recycling endosomes 
The least understood HPS-associated complex is BLOC-2, 
comprised of subunits mutated in HPS types 3, 5, and 6 and 
their mouse models (Di Pietro et al., 2004; Gautam et al., 
2004). BLOC-2 likely plays a regulatory role in LRO biogene-
sis, as BLOC-2–deficient HPS patients lack the lung pathology 
observed in BLOC-3– and AP-3–deficient patients (Huizing 
et al., 2009), and BLOC-2–deficient mice have less severe pig-
mentary and platelet aggregation defects than other HPS mod-
els (Novak et al., 1984, 1988; Zhang et al., 2003; Gautam et al., 
2004). BLOC-2 subunits are conserved throughout vertebrate 
evolution (Daly et al., 2013) and in Drosophila melanogaster 
(Cheli and Dell’Angelica, 2010) but lack obvious structural 
features except for WD40 domains in HPS5 (Zhang et al., 2003) 
and a potential clathrin binding domain in HPS3 (Helip-Wooley 
et al., 2005). BLOC-2 associates with other components re-
quired for LRO biogenesis, including the cell-restricted Rab 
GTPases RAB32 and RAB38 (Bultema et al., 2012) and a co-
hort of BLOC-1 (Di Pietro et al., 2006; Salazar et al., 2006, 
2009), and HPS6 was reported to regulate lysosomal position-
ing and maturation in HeLa cells (Li et al., 2014). However, 
a detailed understanding of how BLOC-2 influences protein 
delivery to LROs is lacking.
Melanosomes in epidermal melanocytes provide an excel-
lent model to dissect HPS-associated complex function in LRO 
biogenesis (Raposo and Marks, 2007; Sitaram and Marks, 2012). 
Nonpigmented stage I and II melanosome precursors segre-
gate from vacuolar early endosomes (Raposo et al., 2001) and 
mature into stage III and IV pigmented granules by delivery of 
melanogenic integral membrane enzymes and transporters via 
tubulovesicular carriers. Melanosome cargo is delivered from 
distinct early endosomal domains via at least two pathways. 
The enzyme tyrosinase (TYR) is primarily delivered to melano-
somes by a pathway that requires AP-3 but not BLOC-1 (Huizing 
et al., 2001; Theos et al., 2005; Setty et al., 2007, 2008). Other 
melanosome cargoes, such as TYR-related protein-1 (TYRP1) 
and oculocutaneous albinism type 2 (OCA2), and a smaller co-
hort of TYR, exploit a distinct pathway that requires BLOC-1 
for cargo exit from vacuolar early endosomes (Setty et al., 2007, 
2008; Sitaram et al., 2012). Melanosomal delivery by this path-
way employs tubular recycling endosomal transport intermedi-
ates that require the adaptor AP-1 and the microtubule motor 
KIF13A for their formation (Delevoye et al., 2009). Other 
known effectors of melanosomal transport such as RAB32, 
RAB38, and their exchange factor, BLOC-3, likely also func-
tion in this pathway, as they are required for melanosome local-
ization of a similar set of cargoes in some melanocytic cells 
(Di Pietro et al., 2006; Wasmeier et al., 2006; Bultema et al., 
2012; Gerondopoulos et al., 2012). Although TYRP1 and TYR 
distributions are altered in BLOC-2–deficient cells (Richmond 
et al., 2005; Helip-Wooley et al., 2007; Setty et al., 2007) and 
BLOC-2 localizes to transferrin-accessible endosomal tubules 
with characteristics of the KIF13A-dependent transport in-
termediates (Di Pietro et al., 2006), it is not known at which 
step BLOC-2 functions in melanosome cargo transport.
Here, we use immortalized melanocytes from mouse HPS 
models, quantitative analyses of melanosome cargo localization 
and trafficking, and live-cell imaging of transport intermediates 
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In contrast to the obligate BLOC-1–dependent cargoes 
TYRP1, ATP7A, and OCA2, localization of the largely BLOC-1– 
independent TYR (Setty et al., 2007, 2008) was less severely 
altered in BLOC-2 cells. TYR accumulated abnormally in the 
perinuclear region (see next paragraph), but TYR distribution 
in the periphery to melanosomes was not substantially reduced 
in BLOC-2 cells relative to WT or BLOC-2R cells, as best ap-
preciated in the more highly pigmented cohort of BLOC-2 cells 
(Fig. 2, j–o; 37 ± 9% of TYR overlapped with pigment granules 
in WT, 32 ± 8% in BLOC-2, and 36 ± 8% in BLOC-2R; differ-
ences were not statistically significant). Consistently, TYR activity 
in BLOC-2 cells, as determined by l-3,4-dihydroxyphenylalanine 
(DOPA; l-DOPA) histochemistry, was comparable to that of 
WT melanocytes and much higher than in control TYR-deficient 
cells. Post-fixation l-DOPA addition induced melanin accu-
mulation primarily in melanosomes by electron microscopy 
(Fig. S2; d-DOPA control shows preexisting melanin), indicat-
ing that TYR was properly localized and active in vitro but less 
active in vivo. Thus, BLOC-2 function is limited to the BLOC-1– 
dependent pathway.
The IFM analyses also revealed a substantial accumulation 
of TYRP1, OCA2, ATP7A, and TYR near the microtubule- 
organizing center of BLOC-2–deficient melan-coa and melan-ru 
cells but not in BLOC-2R cells (Fig. 2 and Fig. S1, large 
arrows); similar accumulation of LAMP2 was sometimes but 
not consistently observed. Because many compartments over-
lap in this region, we exploited quantitative immuno–electron 
marked by syntaxin-13 (STX13). STX13 distribution was gener-
ally similar in BLOC-2 and BLOC-2R cells (Fig. 2 and Fig. S1, 
a–d). Compared with BLOC-2R cells, in which only 14 ± 7% 
of peripheral TYRP1-positive puncta were labeled for STX13 
as in WT melanocytes (Setty et al., 2007), a substantial fraction 
of TYRP1 was mislocalized to STX13-containing early endo-
somes in BLOC-2 (28 ± 7% overlap; Fig. 2, a–f, arrows) and 
melan-ru cells (22 ± 3%; Fig. S1, a–d). This degree of overlap 
was not as high as that observed in BLOC-1 cells (Setty et al., 
2007). Moreover, a small but substantial fraction of TYRP1 
overlapped with or surrounded the faint pigment granules in 
BLOC-2 cells observed by bright-field microscopy (Fig. 2 c, 
arrowheads; see Table 1 for quantification by electron micros-
copy). Consistently, melanosome localization of the peripheral co-
hort of ATP7A—a copper transporter that also requires BLOC-1 
for melanosomal transport (Setty et al., 2008)—was reduced in 
BLOC-2 relative to BLOC-2R cells (Fig. S1, k–p; and Fig. 3). 
As in WT melanocytes (Raposo et al., 2001; Setty et al., 2007), 
TYRP1 in BLOC-2 cells did not overlap appreciably in the 
periphery with either the lysosome marker LAMP2 (Fig. 2, 
g–i) or the early stage melanosome marker PMEL (Fig. S1, 
e–g), but overlapped extensively with the transiently expressed 
BLOC-1–dependent melanosome cargo, OCA2 (Fig. S1, h–j, 
arrowheads; Sitaram et al., 2012). These data indicate that in 
BLOC-2–deficient cells, BLOC-1–dependent cargoes are inef-
ficiently delivered to melanosomes and are partially mislocal-
ized to early endosomes.
Figure 1. BLOC-2 melanocytes are hypopigmented and pigmentation is restored by expression of the deficient BLOC-2 subunit. (a–c) Bright-field micros-
copy analysis of untransfected HPS3-deficient melan-coa (BLOC-2, a) or stable transfectants expressing Muted-HA (melan-coa:MuHA or BLOC-2C, b) or 
hHPS3 (melan-coa:hHPS3 or BLOC-2R, c). Images were taken at identical lighting and camera settings. Insets, 2.5× magnification of boxed regions. Bar, 
10 µm. (d) BLOC-2, BLOC-2C, and BLOC-2R whole cell lysates were fractionated by SDS-PAGE and immunoblotted with antibodies to HPS6, HA epitope, 
or -tubulin as a loading control. (left) Migration of molecular mass markers (in kilodaltons); arrows indicate relevant bands; the asterisk shows a nonspecific 
band recognized by anti-HPS6 antiserum. (e and f) Standard electron microscopy analysis of BLOC-2 and BLOC-2R melanocytes. End., endosomes; II, III, 
and IV, different stages of melanosomes. Bars, 500 nm.
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vacuolar endosomes in BLOC-2 cells (Fig. 3 a and Table 1), 
consistent with IFM results. Minor increases in TYRP1 label-
ing were also observed on multivesicular late endosomes and 
lysosomes (Table 1). Strikingly, TYRP1 labeling on the Golgi 
stacks was 6.5× higher in BLOC-2 relative to BLOC-2R cells, 
representing nearly 20% of all TYRP1 (Fig. 3 and Table 1). La-
beling for ATP7A was also substantially increased in the Golgi 
stacks and on tubulovesicular endosomes in BLOC-2 relative 
to BLOC-2R cells, although sparse labeling on pigment granules 
microscopy on ultrathin cryosections to better define the sites 
of TYRP1 accumulation. In BLOC-2R melanocytes, as has been 
observed previously in WT melanocytes or MNT-1 melanoma 
cells (Raposo et al., 2001; Setty et al., 2007, 2008; Delevoye 
et al., 2009), immunogold labeling for TYRP1 was detected pri-
marily on the limiting membrane of melanosomes with a smaller 
cohort on endosomal tubules and the Golgi (Fig. 3 b and Table 1). 
By comparison, TYRP1 labeling was reduced 2.4× on pigment 
granules (to 31.1%) and increased 1.6× on tubulovesicular and 
Figure 2. TYRP1 but not TYR is partially mis-
localized to early endosomes in the periphery 
of BLOC-2 cells. (a–o) BLOC-2 (a–c and g–l) 
and BLOC-2R (d–f and m–o) melanocytes were 
analyzed by deconvolution IFM after double 
labeling for TYRP1 (a–i) and STX13 (a–f ) or 
LAMP2 (g–i), or transfection with EGFP-STX13 
and labeling for TYR (j–o). Bright-field (BF) im-
ages are shown in c, f, i, l, and o. Insets, 3× 
(j–o) or 3.5× (all others) magnifications of the 
boxed regions as merged images with bright-
field images pseudocolored blue. Arrows in 
insets, examples of overlap between TYRP1 or 
TYR and STX13 in BLOC-2 cells; arrowheads, 
examples of overlap between TYRP1 or TYR and 
pigment granules; large arrows, perinuclear ac-
cumulation of TYRP1 or TYR in BLOC-2 cells. 
Bars, 10 µm.
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plasma membrane, we monitored the rate at which fluorophore-
conjugated anti-TYRP1 antibody in the culture medium was 
internalized and accumulated within cells (Setty et al., 2007). By 
this assay, TYRP1 traversed the plasma membrane at a substan-
tially higher rate in BLOC-2 than BLOC-2R cells, particularly 
was detected in both cell types (Fig. 3). Thus, melanosomal car-
goes of the BLOC-1 pathway are largely mislocalized to the 
Golgi and endosomes in the absence of BLOC-2.
EM analysis of BLOC-2 cells (Fig. 1, Fig. 3, and Fig. S2) 
failed to identify enlarged early endosomal vacuoles like those 
that accumulate in melanocytic cells that lack BLOC-1 (Setty 
et al., 2007, 2008) or are depleted of KIF13A or AP-1 (Delevoye 
et al., 2009). Moreover, TYRP1 and ATP7A accumulated less dra-
matically within vacuolar sorting endosomes than in BLOC-1– 
deficient cells (Setty et al., 2007, 2008). Thus, BLOC-2 does not 
likely function in cargo exit from endosomes but rather in a dis-
crete step of cargo transport.
BLOC-2 antagonizes endocytic recycling  
of melanosomal cargoes
Besides the aberrant localization to early endosomes and the 
Golgi, TYRP1 levels at the plasma membrane—as assessed by 
flow cytometry—were increased (by 3.5–5-fold) in BLOC-2 
and BLOC-2C relative to BLOC-2R cells (Fig. 4 a), despite no 
significant change in total cellular TYRP1 expression (Fig. S3 a). 
Increased surface expression was specific for mature mela-
nosome components because plasma membrane levels of the 
immature melanosome protein PMEL were only modestly in-
creased (Fig. 4 a). Increased TYRP1 surface expression did 
not reflect reduced endocytosis, as TYRP1 endocytic rates 
(Setty et al., 2007; Truschel et al., 2009) were increased—not 
decreased—in BLOC-2, BLOC-2C, and melan-ru cells relative 
to rescued BLOC-2R and melan-ru:HPS6 cells (Fig. 4 b and 
Fig. S3 b). Thus, another mechanism must account for high 
TYRP1 surface expression. Why TYRP1 endocytosis is accel-
erated in BLOC-2–deficient cells is unclear, but likely reflects 
alterations in membrane dynamics specifically during mature 
melanosomal cargo transport because endocytic rates for the 
premelanosomal protein PMEL (Fig. 4 c) and the nonmelano-
somal transferrin receptor (TfR; Fig. 4 d) were either unaffected 
or decreased in BLOC-2 cells, respectively. Decreased TfR 
endocytic rates likely reflected increased TfR expression levels 
(Fig. 4 a and Fig. S3 a) and consequent competition for AP-2 
binding by its tyrosine-based internalization signal (Marks et al., 
1996; Warren et al., 1997) as also observed in BLOC-1 cells 
(Setty et al., 2007; Cullinane et al., 2011); in contrast, TYRP1 
bears a dileucine-based internalization signal and likely en-
gages a distinct saturable binding site on AP-2 (Marks et al., 
1996; Kelly et al., 2008).
If TYRP1 endocytosis is not impaired in BLOC-2 cells, 
the high surface TYRP1 levels must reflect increased delivery 
to the plasma membrane. To probe TYRP1 flux through the 
Figure 3. TYRP1 accumulates in the Golgi of BLOC-2 melanocytes.  
(a and b) Immunoelectron microscopy of ultrathin cryosections from BLOC-2 
(a) and BLOC-2R (b) melanocytes that were immunogold labeled for TYRP1 
using10-nm protein A gold (TYRP1 10) and for ATP7A using 15-nm protein A 
gold (ATP7A 15). GA, Golgi apparatus; II and IV, stage II and IV melano-
somes. Arrows show examples of TYRP1 labeling in the Golgi and stage IV 
melanosomes in BLOC-2 melanocytes (a) and on stage IV melanosomes 
in BLOC-2R cells (b); note labeling on tubular and vacuolar endosomes 
in both cell types. Arrowheads show examples of ATP7A labeling on the 
Golgi and melanosomes in both cell types. Bars, 500 nm.
Table 1. Quantification of TYRP1 immunogold labeling in BLOC-2 and BLOC-2R melanocytes
Cell Golgi TGN Vac. End. TVEs/End. MVBs Mels. TVEs/Mel. Lys. Ves.
BLOC-2 19.6 7.7 7.0 10.8 6.7 31.1 9.1 4.0 4.0
BLOC-2R 3.0 1.3 4.8 5.0 3.0 74.2 7.0 1.5 0.2
Ultrathin cryosections of BLOC-2 or BLOC-2R cells were labeled with antibodies to TYRP1 and ATP7A and protein A conjugated to 10- and 15-nm gold particles, 
respectively. Gold particles decorating each indicated compartment were counted in ≥30 cell profiles each. Values are based on 1,278 gold particles counted in 
BLOC-2 cells and 1,430 in BLOC-2R cells. Vac. End., vacuolar endosomes; TVEs, tubulovesicular endosomes near vacuolar endosomes or the Golgi (TVEs/End.) or 
near melanosomes (TVEs/Mel.); MVBs, multivesicular bodies; Mels, melanosome stages II, III, or IV; Lys., lysosomes; Ves., vesicles of undefined origin. Compartments 
with the most dramatic differences between cell lines are indicated in bold.
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inhibition of protein synthesis with cycloheximide (CHX; Fig. 5). 
Thus, either TYRP1 exits the Golgi more slowly in BLOC-2 
cells or a smaller fraction of the Golgi cohort of TYRP1 in 
BLOC-2 cells is newly synthesized—consistent with an increase 
in recycling to the Golgi from endosomes.
To directly assess TYRP1 recycling to the Golgi, we used 
FRAP after expression of TYRP1-EGFP. TYRP1-EGFP faith-
fully reproduced TYRP1 localization, as it overlapped with 
pigment granules in WT melanocytes and with STX13-labeled 
early endosomes in BLOC-1 melanocytes to the same extent 
as endogenous TYRP1 (unpublished data). WT and BLOC-2  
cells transiently expressing TYRP1-EGFP were treated for 
60 min with CHX to clear newly synthesized TYRP1-EGFP 
from the Golgi. Using spinning-disk microscopy, the Golgi 
region (marked by coexpressed GM130-mCherry [mCh]) 
was bleached with a 488-nm laser and TYRP1-EGFP recovery 
in this region was monitored over time (Fig. 6, a and b; and 
Videos 1 and 2). Fluorescence recovery of TYRP1-EGFP in 
BLOC-2 cells was rapid and returned to 75% of the initial 
intensity over the course of 5 min; in contrast, recovery was 
negligible in WT cells (Fig. 6 c). Similar data were obtained by 
photobleaching only a small region of the Golgi (Fig. S3, c and d), 
suggesting that cargo diffusion within the stacks was minimal. 
Recovery in BLOC-2 cells was mediated by centripetal de-
livery of vesicles along tracks to the Golgi region (Video 2). 
within the first 10 min (Fig. 4 e). The high plasma membrane 
sampling primarily reflected endocytic recycling rather than 
biosynthetic trafficking because the rate of accumulation was 
only modestly reduced by treatment with brefeldin A (BFA; 
Fig. 4 f), which does not affect TYRP1 recycling (Setty et al., 
2007; Truschel et al., 2009). We thus conclude that TYRP1 un-
dergoes excessive endocytic recycling in BLOC-2 cells. The 
misrouting through the cell surface in BLOC-2 cells was not 
as severe as in BLOC-1 melanocytes (Setty et al., 2007), af-
firming that BLOC-1 and BLOC-2 function at distinct steps in 
cargo transport.
BLOC-2 antagonizes retrograde trafficking 
of melanosomal cargoes to the Golgi
Because TYRP1 is delivered to melanosomes via recycling 
endosome carriers (Delevoye et al., 2009) to which BLOC-2 
localizes (Di Pietro et al., 2006), increased TYRP1 endocytic 
recycling in BLOC-2 cells might reflect mistargeting of these 
carriers to the plasma membrane. Similar mistargeting to the 
Golgi might explain the increased Golgi accumulation of TYRP1 
and other cargoes in BLOC-2 cells (Fig. 3). Consistently, the 
intensity of TYRP1 labeling within a “masked” Golgi region 
relative to the whole cell declined at a higher rate in WT (falling 
26 ± 3% by 60 min and 31 ± 3% by 120 min) than in BLOC-2 
cells (falling 18 ± 3% by 60 min and 20 ± 5% by 120 min) after 
Figure 4. Increased TYRP1 cycling through the plasma 
membrane in BLOC-2 melanocytes. (a) Comparison of 
cell surface levels of TYRP1, TfR, or PMEL among BLOC-2, 
BLOC-2C, and BLOC-2R melanocytes by flow cytometry 
after labeling of whole cells on ice with unlabeled pri-
mary and AF488-conjugated secondary antibody. 
The mean fluorescence intensity (MFI) ± SD over 4–15 
experiments, each performed in duplicate or quadrupli-
cate, was normalized to 1.0 for BLOC-2R melanocytes 
within each experiment. (b–d) Quantification of TYRP1 
(b), PMEL (c), and TfR (d) endocytosis rates. BLOC-2, 
BLOC-2C, or BLOC-2R cells were incubated with unla-
beled antibodies on ice and loss of surface antibody 
(detected with fluorescent secondary antibody) over 
time at 37°C was quantified by flow cytometry. MFI at 
each time point was calculated and plotted relative to 
MFI at time 0 (defined as 100%). Values (means ± SD) 
were from two to eight separate experiments performed 
in duplicate. (b and d) P-values are indicated for com-
parison of BLOC-2R to BLOC-2 cells. Values in c were 
not significantly different. (e and f) Quantification of 
TYRP1 flux through the plasma membrane. Uptake of 
saturating levels of fluorescent anti-TYRP1 antibody by 
BLOC-2, BLOC-2R, or BLOC-1–deficient melan-mu cells 
(BLOC-1) at 37°C was quantified over time by flow 
cytometry. In f, cells were left untreated or were treated 
with 10 µg/ml brefeldin A (BFA) for 1 h before and 
during the experiment as indicated. Values (means ± 
SD) were from at least three independent experiments 
performed either in duplicate or quadruplicate and rep-
resent raw MFI (e) or a normalized value (f) calculated as 
the percentage of the MFI value for untreated BLOC-2  
cells at 2 h. P-values shown in e correspond to all points 
in the graph except the initial time point; p-values in f are 
shown only for differences deemed significant between 
BFA and +BFA samples. *, P < 0.05; **, P < 0.01; 
***, P < 0.001; n.s., not significant.
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tubules were longer than 1 µm (Fig. 8 e). Many tubules made 
transient contacts with melanosomes marked by mRFP-OCA2 
(Fig. 8, b and f, arrow). These contacts lasted from a few sec-
onds up to 60 s, with nearly half lasting longer than 20 s (Fig. 8, 
b and g). Qualitatively similar results were obtained using 
bright-field microscopy to visualize pigment granules relative 
to EGFP-STX13 (Fig. S5, a and b). These events reflect the pre-
viously described interactions between transport intermediates 
and melanosomes (Delevoye et al., 2009).
Relative to WT cells, similar numbers of EGFP-STX13–
containing tubules were generated (Fig. 8, a, b [arrowheads], 
c, and d; and Videos 5 and 6) in BLOC-2 cells, but tubule length 
was significantly reduced such that the majority of tubules were 
Thus, retrograde trafficking of TYRP1 to the Golgi is markedly 
enhanced in BLOC-2 cells.
To test whether increased retrograde trafficking in BLOC-2 
cells was specific to melanosome cargoes, we used internal-
ized Alexa Fluor 488 (AF488)–conjugated cholera toxin B 
subunit (CTxB; CTxB-AF488) as a probe (Sandvig et al., 2013). 
Cells were pulsed with CTxB-AF488, and accumulation within 
the Golgi region was monitored at different times by IFM. Un-
like for TYRP1, the rate of CTxB-AF488 accumulation in the 
Golgi region over 4 h was significantly reduced in BLOC-2, 
BLOC-2C, and melan-ru cells compared with WT melan-Ink4a, 
BLOC-2R, and rescued melan-ru:HPS6 melanocytes (Fig. 6, 
d and e). These data indicate that the increased retrograde traf-
ficking in BLOC-2–deficient cells is specific to a melanosome 
cargo and not generalizable. The specific increases in TYRP1 
trafficking to the plasma membrane and to the Golgi region are 
consistent with a model in which BLOC-2 diverts melanosome 
cargo from other destinations of recycling endosomes and to-
ward melanosomes.
Stability and melanosome targeting 
of endosomal transport intermediates 
requires BLOC-2
We next considered whether BLOC-2 influences the dynamics 
of the recycling endosomal transport intermediates through which 
cargoes are delivered to maturing melanosomes (Delevoye et al., 
2009). To visualize the intermediates, we exploited the pan- 
endosomal SNARE, STX13, tagged with EGFP or mCh. By 
immuno–electron microscopy, EGFP-STX13 expressed stably 
in human MNT-1 melanoma cells (in which the intermediates 
have been characterized; Delevoye et al., 2009) was detected on 
tubulovesicular structures and vacuolar endosomes with bilay-
ered clathrin coats (Fig. 7, a and b), as observed for endogenous 
STX13 in other cell types (Prekeris et al., 1998; De Mazière 
et al., 2002). Labeling was particularly evident on tubules that 
emanated from vacuolar endosomes and that closely apposed 
and/or contacted melanosomes (Fig. 7, c and d), at least some 
of which were associated with AP-1 and/or contained TYRP1 
(Fig. S4). Moreover, when expressed in WT mouse melanocytes 
and analyzed by live-cell spinning-disk microscopy, EGFP- or 
mCh-STX13 decorated vacuolar, punctate, and tubular struc-
tures with similar features as in MNT-1 cells (Fig. 7, e–l; and 
Fig. 8). Tubules labeled for both mCh-STX13 and GFP-RAB11A 
(enriched in recycling endosomes) emanated from puncta labeled 
by both mCh-STX13 and GFP-RAB5A (enriched on sorting 
endosomes; Fig. 7, e–l), as expected for the transport intermediates 
(Delevoye et al., 2009, 2014). Thus, EGFP- and mCh-STX13 
label vacuolar endosomes and recycling endosomal tubular 
transport intermediates through which TYRP1 is transferred 
to melanosomes.
To visualize the transport intermediates relative to mela-
nosomes, BLOC-2 or WT melanocytes that stably express 
EGFP-STX13 were transiently transfected with mRFP-tagged 
OCA2 to label melanosomes and analyzed by spinning-disk 
microscopy. In WT cells, the EGFP-STX13–labeled tubules were 
very dynamic (Fig. 8, a and b, arrowheads; and Video 3). Tubule 
length varied widely (Fig. 8 c and Video 4), but the majority of 
Figure 5. TYRP1 that accumulates in the Golgi of BLOC-2 melanocytes 
is not newly synthesized. WT melan-Ink4a or BLOC-2 cells on coverslips 
were treated with CHX at 37°C for the indicated times, and then fixed, 
labeled for TYRP1 and the Golgi marker giantin, and analyzed by IFM. 
(a) Representative deconvolved images of TYRP1 labeling at the 0 and 
120 min time points. Red outline, Golgi region defined by giantin labeling. 
Bar, 10 µm. (b) The intensity of TYRP1 in the giantin-positive Golgi region 
was quantified relative to total TYRP1 fluorescence and plotted over time. 
Data represent means ± SD from ≥50 cells in three independent experi-
ments. *, P < 0.05; **, P < 0.01.
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shorter than 1 µm (Fig. 8, c and e). Importantly, the frequency 
with which these tubules contacted mRFP-OCA2–labeled puncta 
was dramatically reduced in BLOC-2 cells (Fig. 8, b and f). 
For those tubules that did contact mRFP-OCA2–labeled puncta 
in BLOC-2 cells, the duration of contact was much shorter 
than in WT cells, such that >95% lasted fewer than 20 s (Fig. 8, 
b and g). Qualitatively similar results were obtained using bright-
field microscopy to identify melanosomes (Fig. S5, c and d). 
The requirement for BLOC-2 in tubule dynamics was specific 
for the transport intermediates labeled by EGFP-STX13, as 
neither the number nor length of distinct tubules, labeled by 
GFP-VAMP8, was changed in BLOC-2–deficient melan-ru 
cells relative to rescued melan-ru:HPS6 cells (Fig. S5, e–j). 
Thus, endosome-derived tubules are less likely to establish and 
maintain contacts with melanosomes in the absence of BLOC-2. 
Figure 6. Retrograde trafficking of TYRP1 to 
the Golgi is specifically increased in BLOC-2 
melanocytes. (a–c) WT melan-Ink4a or BLOC-2  
cells transiently expressing TYRP1-EGFP and 
GM130-mCh to mark the Golgi, were pre-
treated with CHX for 60 min at 37°C and 
then imaged by spinning disk microscopy (t = 0). 
GFP fluorescence within the Golgi region la-
beled by GM130-mCh was bleached at frame 
5 (t = 5), and recovery of TYRP1-EGFP fluor-
escence intensity was quantified over time 
by normalizing to prebleach GFP intensity 
of the same region. (a and b) Representative 
images for GM130-mCh and TYRP1-EGFP 
from t = 0, t = 5, and t = 300 (300 s) for WT 
(a) and BLOC-2 cells (b). Bleached region is 
indicated by the dotted white line in TYRP1-
EGFP images. Bars, 10 µm. (c) Quantification 
of fluorescence recovery. Rel., relative; fl., 
fluorescence. Values represent the means ± 
SD of GFP intensity traces of 15 cells of each 
type. (d and e) WT (melan-Ink4a), “rescued” 
BLOC-2R (melan-coa:hHPS3), or melan-ru:
HPS6, or BLOC-2–deficient BLOC-2 (melan-
coa), BLOC-2C, or melan-ru cells on cover-
slips were incubated with AF488-conjugated 
CTxB on ice for 1 h and then at 20°C for 15 min 
to allow for internalization. Cells were washed 
once and incubated at 37°C for the indicated 
times, fixed, labeled with the anti-giantin anti-
body and analyzed by IFM. (d) Representa-
tive CTxB fluorescence images of BLOC-2 
and BLOC-2R cells at the 0 and 90 min time 
points (t = 0, t = 90) showing appearance of 
CTxB in the Golgi (giantin staining; red out-
line) by 90 min. Bar, 10 µm. (e) Fluorescence 
intensity of AF488-CTxB in the giantin-positive 
region was quantified and plotted over time 
for all cell types. Values (means ± SD) for 
all BLOC-2–deficient lines are significantly dif-
ferent (P < 0.01 at 60 min and P < 0.001 at 
120 and 240 min) from their paired BLOC-2– 
sufficient lines.
Together with the cargo localization and dynamics results, the 
data suggest that BLOC-2 favors melanosomal cargo delivery 
by specifying recycling endosomal transport intermediates to 
interact with maturing melanosomes.
Discussion
The protein complexes that are defective in most characterized 
HPS isoforms participate in cargo delivery to LROs such as 
melanosomes, but it was unknown how BLOC-2 functions. We 
show here that BLOC-2 facilitates the targeting of endosomal 
transport carriers specifically to melanosomes, averting “de-
fault” delivery to the plasma membrane and the Golgi—classical 
targets of recycling endosomes. These data are consistent with 
a role for BLOC-2 in mediating interactions between maturing 
571BloC-2 directs transport carriers to melanosomes • Dennis et al.
Figure 7. EGFP-STX13 labels recycling endosomal-derived transport intermediates in melanocytic cells. (a–d) Ultrathin cryosections of fixed human MNT-1 
melanoma cells that stably express EGFP-STX13 were labeled with anti-GFP antibody and protein A conjugated to 10-nm gold particles (PAG10) and 
then analyzed by electron microscopy. Arrowheads point to vesicular structures associated with melanosomes (M; a and d) or endosomes (E; b); arrows 
(c and d) point to tubules that are continuous with endosomes or melanosomes; triangles (b) point to a bilayered clathrin coat on a vacuolar endosome. 
Bars, 200 nm. (e–l). WT melan-Ink4a mouse melanocytes were transiently transfected with mCh-STX13 and either GFP-RAB5A (e–h) or GFP-RAB11A (i–l) and 
analyzed 24 h later by spinning-disk confocal microscopy. (e and i) Single frames of representative cells showing overlap of mCh-STX13 with RAB5A- 
labeled vesicles (e) or RAB11A-labeled tubules (i). Bars, 10 µm. Image sequences from the boxed region in e and i are shown magnified 3× in f–h and j–l, 
respectively, with each label shown individually in black and white (f, g, j, and k) and merged images shown in color (h and l); elapsed time in seconds is 
indicated at bottom right. In f–h, an mCh-STX13–labeled tubule (yellow arrows) emerges from a GFP-RAB5–labeled punctate structure (white arrowheads). 
In j–l, a tubule (yellow arrows) is labeled for both mCh-STX13 and GFP-RAB11A. Bars, 2 µm.
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LROs and tubular recycling endosome-derived transport carri-
ers ferrying LRO cargoes.
Our analyses of melanosome cargo distribution in BLOC-2– 
deficient melanocytes show a unique pattern of cargo mislo-
calization among HPS models. HPS 2, 8, and 9 models that lack 
AP-3 or BLOC-1 display defects in cargo exit from early endo-
somes into melanosome-bound transport carriers, resulting in 
altered early endosome morphology and cargo entrapment in 
early endosomes (Huizing et al., 2001; Theos et al., 2005; Setty 
et al., 2007, 2008; Delevoye et al., 2009). As in BLOC-1 cells 
(Setty et al., 2007; Cullinane et al., 2011), TYRP1 in BLOC-2 
cells undergoes increased cycling to the plasma membrane 
and is modestly enriched in early endosomal compartments, 
likely as a result of repeated cycles of recycling and endocyto-
sis. However, unlike in BLOC-1 cells, TYRP1 in BLOC-2 
cells also accumulates in the Golgi; our FRAP and CHX chase 
analyses suggest that this cohort reflects increased retrograde 
trafficking. The primary sites of TYRP1 misaccumulation—the 
plasma membrane and the Golgi—are both targets of recycling 
endosomes in other cell types (Maxfield and McGraw, 2004; 
Bonifacino and Rojas, 2006). Because recycling endosomes 
serve as carriers through which TYRP1 is delivered to mela-
nosomes (Delevoye et al., 2009), our data indicate that cargoes 
appropriately enter these transport carriers in BLOC-2 cells. 
Figure 8. BLOC-2 facilitates contacts of recycling endosomal tubules with maturing melanosomes. WT melan-Ink4a and BLOC-2 cells stably expressing 
EGFP-STX13 were transfected with mRFP-OCA2 and imaged in a single plane at 1 fps for 5 min by spinning disk microscopy. (a) Starting frame from 
representative image series (Videos 3 and 5). Boxed region is magnified 2× in inset. Bar, 10 µm. (b) Frames from the image series of the magnified boxed 
region in a at the times (seconds) indicated in top left. Arrows, melanosomes that interact with tubules; arrowheads, examples of tubules. (c) EGFP-STX13 
labeling in a single panel highlighted in b was analyzed using the ImageJ “skeletonize” function to emphasize tubule length (Videos 4 and 6 for image 
series). (d) The number of EGFP-STX13 tubules (branched structures in skeletonized images) per video frame using a constant frame size (12 × 12 µm) was 
quantified within at least five WT and BLOC-2 cells in each of three independent experiments. Shown is the mean number of tubules (±SD) identified in 
each frame. (e) The length of EGFP-STX13 tubules between vertices in skeletonized images was quantified within 10 WT and BLOC-2 cells each in three 
independent experiments. Shown are the percentages (means ± SD) of tubules with lengths shorter or longer than 1 µm. (f) The percentage of EGFP-STX13 
tubules that contact mRFP-OCA2–positive compartments was quantified using a MATLAB program and averaged from five WT and BLOC-2 cells each in 
six independent experiments. Shown are the mean values ± SD. (g) For those EGFP-STX13 tubules that contact mRFP-OCA2 compartments, the duration of 
contact was quantified. Shown are the percentages of contacts (means ± SD) that lasted for greater or less than 20 s. *, P < 0.05; **, P < 0.01.
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interaction between BLOC-2 and the dynein–dynactin complex 
(Li et al., 2014).
Our data suggest that BLOC-2 functions specifically on 
the tubular transport carriers observed here, which correspond 
to the TfR- and RAB11-enriched tubules described in human 
MNT-1 melanocytic cells (Delevoye et al., 2009) to which 
BLOC-2 has been localized (Di Pietro et al., 2006). As with those 
tubules (Delevoye et al., 2014), the tubules observed here ema-
nate from vacuolar sorting endosomes and are enriched in re-
cycling endosome markers such as STX13 and RAB11 but not 
in VAMP8, which marks a distinct class of dynamic membrane 
tubule that is not influenced by BLOC-2. They likely correspond 
to transport carriers specific to the BLOC-1–dependent pathway 
because the cargoes that are most depleted from melanosomes 
in BLOC-2 melanocytes—TYRP1, ATP7A, and OCA2—are 
obligate BLOC-1 cargoes (Setty et al., 2007, 2008; Sitaram 
et al., 2012). In contrast, TYR was only partially affected, as 
also observed in BLOC-1 cells (Setty et al., 2007, 2008) and 
indicated by its aberrant accumulation in the Golgi but near nor-
mal accumulation in melanosomes. This is also consistent with 
observations in melanocytes from HPS3 patients (Boissy et al., 
2005). If BLOC-2 indeed functions as a tether as we hypothe-
size, we predict that a distinct tether functions for the BLOC-1– 
independent/AP-3–dependent delivery of TYR; because nor-
mal TYR localization and expression levels require RAB32 and 
RAB38 (Wasmeier et al., 2006; Bultema et al., 2012), such a 
tether would likely be another RAB32/38 effector.
Despite a substantial cohort of TYR within melanosomes 
in BLOC-2 cells and near normal levels of post-fixation TYR 
activity, BLOC-2 cells are nevertheless hypopigmented. Our 
observations that melanosomal transmembrane transporters such 
as OCA2 are mislocalized in BLOC-2 cells provide a poten-
tial explanation. OCA2 facilitates a chloride conductance that 
neutralizes intralumenal pH in maturing melanosomes, a require-
ment for TYR activity (Bellono et al., 2014). Reduced intra-
lumenal pH, resulting from a reduced content of OCA2 and/or 
other transporters in melanosomes, would reduce TYR activity 
in vivo but not upon organelle permeabilization in vitro. Loss 
of transporter activity for an osmolyte, as predicted for the pig-
ment cell-specific SLC45A2 proton-dependent sucrose trans-
porter (Newton et al., 2001; Bartölke et al., 2014), might also 
explain why melanosomes in BLOC-2 melanocytes are unusu-
ally small (Suzuki et al., 2001; Zhang et al., 2003; Boissy et al., 
2005; Helip-Wooley et al., 2007). Interestingly, unlike in BLOC-1 
cells, sufficient levels of ATP7A are present in melanosomes in 
BLOC-2 melanocytes such that excess copper is not needed to 
observe copper-dependent TYR activity upon fixation. This is 
consistent with an ancillary role of BLOC-2 in cargo delivery 
as expected for a tether.
Materials and methods
Reagents
Chemicals were obtained from Sigma-Aldrich, except where noted. FuGENE 6, 
hygromycin B, and protease inhibitors were obtained from Roche. Tissue 
culture reagents, Matrigel, and Lipofectamine 2000 were obtained from 
Invitrogen. Protein A conjugated to 10- or 15-nm gold particles was from Cell 
Microscopy Center (Academisch Ziekenhuis Utrecht, Utrecht, Netherlands).
However, the carriers are largely diverted to other destinations, 
effectively reducing cargo delivery to melanosomes. This is 
distinct from the cargo transport defects in BLOC-1–deficient 
cells, in which TYRP1 fails to exit sorting endosomes (Setty 
et al., 2007, 2008; Cullinane et al., 2011) or in AP-1– or KIF13A-
depleted cells in which the transport intermediates fail to form 
at all (Delevoye et al., 2009, 2014). The rapid movement of the 
carriers and lack of cargo accumulation in the vacuolar endo-
somes from which they originate likely explain why cargoes 
do not accumulate within the carriers themselves. Thus, our 
data support a model in which BLOC-1, AP-1, and KIF13A 
function during cargo exit from endosomes into transport car-
riers, and BLOC-2 facilitates the subsequent delivery of these 
carriers to melanosomes.
The results of our live-cell imaging analyses suggest that 
redirection of melanosome-bound cargo in BLOC-2 cells is 
caused by the loss of a specific interaction between endosomal 
cargo transport intermediates and maturing melanosomes. 
Whereas numerous recycling endosomal tubules in WT mela-
nocytes underwent prolonged interactions with melanosomes 
marked by mRFP-OCA2 or pigmentation, such interactions 
were fewer and shorter in duration in BLOC-2 melanocytes. 
Although OCA2 is partially mislocalized in BLOC-2 melano-
cytes, tubule contacts with OCA2-labeled structures were more 
dramatically reduced than melanosome localization. The sim-
plest explanation for these data is that BLOC-2 functions as a 
melanosome (or LRO)-specific tether for the tubular transport 
intermediates. This hypothesis is consistent with the immuno-
localization of BLOC-2 to transferrin-containing recycling en-
dosomal tubules (Di Pietro et al., 2006) and is supported by 
several observations. First, cargo delivery to melanosomes is 
impaired but not completely ablated in BLOC-2 cells, consis-
tent with tethering defects in other systems and with the abil-
ity of SNAREs to function, albeit inefficiently, in the absence 
of tethering (Bröcker et al., 2010). Second, BLOC-2 is an ef-
fector of RAB32 and RAB38 and is recruited to membranes 
in part by RAB38 (Bultema et al., 2012); RAB32 and RAB38 
function in membrane trafficking to melanosomes (Wasmeier 
et al., 2006; Bultema et al., 2012), and Rab interactions are a 
common feature of tethers (Bröcker et al., 2010). Third, TYR 
activity accumulates abnormally in vesicles in addition to me-
lanosomes by electron microscopy of melanocytes from human 
HPS3 patients (Boissy et al., 2005), supporting a nonessential 
but important role in fusion of transport intermediates with 
target melanosomes. Finally, although BLOC-2 subunits lack 
sequence homology with known trafficking elements, tether-
ing protein complexes often have poor sequence homology de-
spite extensive structural similarity (Jackson et al., 2012). Other 
potential functions for BLOC-2 are possible but less consistent 
with our data. For example, BLOC-2 might function to stabi-
lize the endosomal tubules rather than tether them; however, 
this would be less consistent with the more dramatic effects 
of BLOC-2 deficiency on the number and duration of contacts 
with melanosomes than on tubule length. Because the tubules 
that we observe likely require the plus end–directed kinesin-3 
motor KIF13A for their formation (Delevoye et al., 2009, 
2014), our data are not consistent with a proposed functional 
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subcloned into the MMLV-based pBMN-IRES-Hygro X/N retroviral vector 
to generate pBMN-EGFP-STX13. mCH-STX13 controlled by the CMV pro-
moter was generated by subcloning mCh into pEGFP-C1-STX13 using the 
AgeI–BsrGI region of mCh from pmCh-C1 (Takara Bio Inc.). TYRP1-EGFP 
controlled by the CMV promoter was generated by amplifying the human 
TYRP1 cDNA from pCDNA3-TRP1 (a gift from W. Storkus, University of 
Pittsburgh, Pittsburgh, PA) flanked with EcoRI and SalI sites and subcloning 
into pEGFP-N1 (Takara Bio Inc.). An XhoI–NotI fragment encompassing 
the TYRP1-EGFP fusion was then subcloned into pBMN-IRES-Hygro X/N to 
generate the retroviral pBMN-TYRP1-EGFP vector under the control of the 
MMLV promoter. To generate pCR3-mRFP-OCA2 in which mRFP-OCA2 is 
expressed from the CMV promoter, mRFP with flanking BamHI and Acc65I 
sites was subcloned from pCMV-mRFP (a gift from R. Tsien, University of 
California, San Diego, La Jolla, CA via G. Koretzky, Weill Cornell Medi-
cal College, New York, NY) into the coding region for the N terminus 
of OCA2 with a lumenal HA epitope in pCR3-OCA2-HA (Sitaram et al., 
2009). GM130-mCh controlled by the CMV promoter was a gift from 
J. Lippincott-Schwartz (National Institutes of Health, Bethesda, MD). GFP-
VAMP8 in pEGFP-C vector, controlled by the CMV promoter and generated 
from mouse cDNA, was a gift from P. Roche (National Institutes of Health, 
Bethesda, MD). GFP-RAB5A and -RAB11A encoding human RAB isoforms 
in pEGFP-C vectors and controlled by the CMV promoter were gifts from 
B. Goud (Institut Curie, Paris, France).
Electron microscopy
For conventional electron microscopy analyses, cells were fixed with 2% 
paraformaldehyde and 1% glutaraldehyde, post-fixed with osmium tetrox-
ide and ferrocyanide and embedded in Epon, and ultrathin sections were 
prepared with an ultramicrotome (Reichert UltracutS; Leica) as previously 
described (Raposo et al., 2001). DOPA immunohistochemistry analysis 
was performed on cells fixed for 1–2 h in Karnovsky’s fixative and 0.5% 
glutaraldehyde by incubation with 0.1% (wt/vol) l-DOPA (or d-DOPA as 
a negative control) in cacodylate buffer followed by fixation as previously 
described (Setty et al., 2008) and processing as outlined above. For immuno-
electron microscopy, cells were fixed with 2% paraformaldehyde and 
0.2% glutaraldehyde, embedded in 10% (wt/vol) gelatin, infused in 2.3 M 
sucrose, and frozen in liquid nitrogen as previously described (Raposo 
et al., 1997). Ultrathin cryosections were prepared with an ultracryomicro-
tome (Ultracut FCS; Leica) as previously described (Raposo et al., 1997) 
and single or double immunogold labeled with antibodies and protein A 
coupled to 10- or 15-nm gold particles. Sections were analyzed on an 
electron microscope (Philips CM120; FEI) using a digital numeric camera 
(Keen View; Soft Imaging System). Quantification of immunogold labeling 
on different organelles was performed as previously described (Theos et al., 
2005). In brief, gold particles associated with the indicated compartments, 
defined morphologically, were counted in ≥30 different profiles of each 
cell type on at least two grids. Golgi, lysosomes, melanosomes (stages II–IV), 
multivesicular bodies (with more than three internal vesicles), and vacuolar 
endosomes (with three or less internal vesicles) were defined by classical 
morphological features; tubulovesicular elements were characterized as 
near vacuolar endosomes or melanosomes. The data in Table 1 represent 
the mean percentage of gold particles in each compartment over at least 
two separate experiments.
Flow cytometry
Cell surface expression, endocytosis, and cell surface delivery assays 
were performed as described previously (Setty et al., 2007) using flow 
cytometry on a FACScan or FACSCalibur instrument and CellQuest Pro 
software (BD). In brief, for cell surface labeling, cells in suspension were 
labeled on ice with primary and fluorophore-conjugated secondary anti-
bodies and analyzed directly by flow cytometry. To quantify endocyto-
sis, unlabeled antibody was bound to the surface of cells in suspension 
in ice, and cells were warmed to 37°C for various periods of time to 
allow endocytosis. Loss of surface-bound antibody was quantified using a 
fluorophore-conjugated secondary antibody and flow cytometry analysis. 
For cell surface delivery, cells were incubated with growth medium contain-
ing AF488-conjugated anti-TYRP1 antibody for 30 min on ice and then 
additionally at 37°C for various periods of time before washing and flow 
cytometry analysis. In some experiments, 10 µg/ml BFA was included 
during a 60-min preincubation and throughout the experiment to block 
biosynthetic cargo delivery.
Immunoblotting
Whole cell lysates were fractionated by SDS-PAGE and analyzed by 
immunoblotting with alkaline phosphatase–conjugated secondary antibodies 
Cell culture and generation of stable cells
Immortal melanocyte cell lines melan-coa2 (HPS3 deficient; BLOC-2) de-
rived from C57BL/10J Hps3coa/coa (cocoa) mice (Suzuki et al., 2001), 
melan-mu (BLOC-1 deficient) from B6.CHMU/Le Mutedmu/mu (muted) mice 
(Setty et al., 2007), and WT melan-Ink4a-Arf-1 (formerly called melan-
Ink4a-1; referred to here as melan-Ink4a or WT) from C57BL/6 Ink4a-
Arf/ mice (Sviderskaya et al., 2002) have been described and were 
derived from the skins of neonatal mice. The immortal melanocyte cell line 
melan-ru-1 (HPS6 deficient) was grown from skins of neonatal C57BL/6J 
Hps6ru/ru (ruby eye) mice after crossing to Ink4a-Arf/ mice and selecting 
double homozygotes as previously described (Setty et al., 2007). All cells 
were cultured in RPMI 1640 medium supplemented with 10% FBS (Atlanta 
Biologicals) and 200 nM 12-O-tetradecanoylphorbol-13-acetate (Sigma-
Aldrich). Retrovirus production from transiently transfected 293T cells or 
Plat-E cells (Morita et al., 2000), transduction, and selection of stable im-
mortalized melanocyte cell lines with 200 µg/ml hygromycin were as pre-
viously described (Setty et al., 2007). Stable transfectants were occasionally 
treated with 200 µg/ml hygromycin B for 2–3 d to maintain selective pres-
sure for the transgene. For FRAP experiments, cells were transiently trans-
fected with pEGFP-N1-TYRP1-EGFP and GM130-mCh using Lipofectamine 
2000 and imaged 24 h later. For live-cell imaging of STX13 relative to Rab 
proteins, cells were transiently transfected with pBMN-mCh-STX13 and ei-
ther GFP-RAB5A or GFP-RAB11A and imaged 24 h later. For live cell imag-
ing of STX13 tubules, stable cell lines expressing EGFP-STX13 from a pBMN 
retroviral vector were transiently transfected with pCR3-mRFP-OCA2-HA and 
visualized after 48 h. Stable transductants of human MNT-1 melanoma cells 
expressing EGFP-STX13, cultured as previously described (Raposo et al., 
2001), were generated by recombinant retroviral transduction and selec-
tion with 200 µg/ml hygromycin.
Antibodies
The following monoclonal antibodies were used: mouse anti-TYRP1 (TA99) 
and anti-MYC epitope (9E10) were obtained from ATCC; rat anti–mouse 
LAMP1 (1D4B) and LAMP2 (GL2A7) were obtained from Developmental Stud-
ies Hybridoma Bank (University of Iowa, Iowa City, IA); mouse anti-PMEL 
(HMB-45, used for IFM) was purchased from Lab Vision; rat anti–mouse 
TfR (CD71, used for endocytosis and recycling assays) was obtained from 
BD; mouse anti–human TfR (H68.4, used for immunoblotting) was pur-
chased from BioGenex; mouse anti-HA.11 was purchased from Covance; 
and mouse anti–-adaptin (100/3) and mouse anti–-tubulin (GTU88) 
were purchased from Sigma-Aldrich. Polyclonal rabbit antisera to HPS6 
(a gift from V. Faundez, Emory University, Atlanta, GA; Gautam et al., 
2004), STX13 (Prekeris et al., 1998), ATP7A (Setty et al., 2008), TYR (Calvo 
et al., 1999), and the N terminus of mouse PMEL (used for the endocytosis 
assay; Theos et al., 2006) have been described previously. Rabbit anti-
giantin was obtained from Abcam (ab24586); rabbit anti-MYC (C-14) and 
anti-TYRP1 (H-90), used for immunoblotting, were obtained from Santa 
Cruz Biotechnology, Inc.; and rabbit anti-GFP was purchased from Invit-
rogen. Species- and/or mouse isotype–specific secondary antibodies from 
donkey or goat conjugated to AF488, Alexa Fluor 594, phycoerythrin, or 
DyLight 488 or 594 used in IFM and flow cytometry or conjugated to alka-
line phosphatase for immunoblotting were either obtained from Invitrogen 
or Jackson ImmunoResearch Laboratories, Inc. Purified TA99 anti-TYRP1 
antibody was conjugated to AF488 using a kit from Invitrogen.
DNA constructs
The retroviral construct pBMN-hHPS3-IRES-Hygro N/X encoding human 
HPS3 (hHPS3) under the control of the Maloney murine leukemia virus 
(MMLV) promoter was generated by subcloning the NotI–XbaI cDNA frag-
ment from hHPS3/pCMV6-XL5 (obtained from OriGene; IMAGE [Inte-
grated Molecular Analysis of Genomes and their Expression] ID TC127283; 
GenBank accession no. NM_032383) into the pCI vector (Promega), and then 
subcloning the resulting NotI–XhoI fragment into the MMLV-based retroviral 
vector pBMN-IRES-Hygro N/X (Setty et al., 2007). MMLV-based retroviral 
vectors encoding mouse HPS5 and HPS6 were generated by subcloning 
the SalI–NotI cDNA fragments (mHPS5-IMAGE ID 6405811 and mHPS6-
IMAGE ID 3673655 obtained from ATCC) directly into the XhoI–NotI sites 
of pBMN-IRES-Hygro X/N. pBMN-MuHA encoding HA-tagged human 
Muted controlled by the MMLV promoter was previously described (Setty 
et al., 2007). EGFP-STX13 was generated by amplifying the coding re-
gion for human Syntaxin 12 (also known as STX13; obtained from ATCC: 
IMAGE ID 3851266), flanked by BamH1 and XhoI sites and subcloning 
into the BglII–SalI sites of pEGFP-C1 (Takara Bio Inc.), and is controlled by 
the human cytomegalovirus (CMV) immediate early promoter. The EGFP-
STX13 fusion was then amplified flanked by BamH1 and XhoI sites and 
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Live-cell imaging of EGFP-STX13–, mCH-STX13–, EGFP-RAB5A–, EGFP-
RAB11A–, and EGFP-VAMP8–expressing cells. WT or BLOC-2 cells were 
plated on Matrigel-coated 35-mm glass-bottom dishes and transiently trans-
fected with EGFP-STX13, mCH-STX13, EGFP-RAB5A, EGFP-RAB11A, and/or 
EGFP-VAMP8 as indicated using Lipofectamine 2000. 24 h after transfec-
tion, cells in culture medium were imaged on a spinning-disk confocal mi-
croscope (UltraVIEW) equipped with an environmental chamber at 37°C, 
a camera (Orca ER), and Volocity for image acquisition. All images were 
captured at 1 fps.
Live-cell imaging of EGFP-STX13 stable cells. WT or BLOC-2 cells sta-
bly expressing EGFP-STX13 were plated on Matrigel-coated 35-mm glass-
bottom dishes and transiently transfected to express mRFP-OCA2. Cells 
were visualized by spinning-disk confocal microscopy equipped with an 
environmental chamber at 37°C/5% CO2. Time-lapse microscopy was 
performed by capturing images over 5 min at 1 fps using a spinning-disk 
microscope (IX71; Olympus) equipped with an electron multiplying charge-
coupled device camera (ImagEM; Hamamatsu Photonics) and IPLab (BD) 
or MetaMorph (Molecular Devices) software. Image sequences were fur-
ther analyzed either with ImageJ or MATLAB (MathWorks, Inc.) software. 
Images were processed into binary and skeletonized, and tubule length 
and number were quantified from each skeletonized video frame (equal 
frame area in each video) using the Analyze Particles plugin in ImageJ 
software. Values were averaged per video. Tracking of EGFP-STX13 and 
mRFP-OCA2 merging and splitting events was performed with MATLAB 
software applying a modified version of a previously described algorithm 
(supplemental material; Jaqaman et al., 2008).
Quantification of EGFP-VAMP8 tubules. To measure tubule number 
and length, images were cropped within ImageJ to remove adjacent cells 
and the nuclear region of each analyzed cell, and then converted to a 
binary image and skeletonized. The skeletonized image series was quan-
tified using the Analyze Skeleton plugin. Features with a mean branch 
length of 5–50 pixels were included in the analysis. For analysis of tube 
number per area, the total cell area was measured in ImageJ and used 
for normalization.
Statistical analysis
Statistical significance was determined by the unpaired Student’s t test and 
analysis of variance. *, P < 0.05; **, P < 0.01; and ***, P < 0.001.
Online supplemental material
Fig. S1 shows colocalization analyses of: TYRP1 with STX13 in a second 
BLOC-2–deficient line (melan-ru); TYRP1 with PMEL and with OCA2-HA in 
BLOC-2 cells; and ATP7A with pigment granules in BLOC-2 and BLOC-2R  
cells. Fig. S2 shows tyrosinase activity and protein expression levels in 
BLOC-2 and BLOC-2R cells. Fig. S3 shows expression levels of relevant 
proteins in BLOC-2, BLOC-2C, and BLOC-2R cells, TYRP1 endocytic rates 
in melan-ru and melan-ru:HPS6 cells, and a FRAP analysis of a small region 
of the Golgi in WT and BLOC-2 cells. Fig. S4 shows immunoelectron mi-
croscopy analysis of EGFP-STX13 relative to TYRP1 or AP-1 in MNT-1 cells. 
Fig. S5 shows live-cell imaging of WT and BLOC-2 cells by alternating 
bright field and fluorescence microscopy to visualize GFP-STX13 relative 
to pigment granules, and of rescued melan-ru:HPS6 and BLOC-2–deficient 
melan-ru cells to visualize and quantify GFP-VAMP8–containing tubules. 
Videos 1 and 2 show recovery of TYRP1 fluorescence intensity in the Golgi 
after photobleaching in WT and BLOC-2 cells, respectively. Video 3 and 5 
show live imaging of WT (Video 3) or BLOC-2 (Video 5) melanocytes 
expressing both EGFP-STX13 and mRFP-OCA2. Videos 4 and 6 show skel-
etonized trajectories of EGFP-STX13 in WT (Video 4) or BLOC-2 (Video 6) 
melanocytes. The source code for the MATLAB software used to quantify 
the interaction of EGFP-STX13 and mRFP-OCA2 in Fig. 8, modified from 
Jaqaman et al., 2008, is provided online as a ZIP file and contains the 
following files. Colorutrack notes.txt provides a brief description of how to 
use the script. colorutrack.m is the central script used to select the series of 
images to be analyzed, and calls the detection and tracking scripts. match-
points.m processes the results of colorutrack.m (TrackingG.mat, TrackingR.
mat, trackfinal_g.mat, and trackfinal_r.mat), extracts the x and y posi-
tions and amplitude of each tracked feature, and then searches for the 
feature within each frame of the image sequence. eventInfo.m uses data 
files produced by colorutrack and matchpoints to count discrete events 
(in this case, contacts between red and green features) and count the 
duration (number of frames) of each discrete event. /example_data_for_
matchpoints.m/movieInfo_g.mat and /example_data_for_matchpoints.m/ 
movieInfo_r.mat provide sample movieInfo data produced by colocation. 
m for a green channel and a red channel, respectively, to be used with 
the matchpoints script. /example_data_for_matchpoints.m/tracksfinal_g.mat 
and enhanced chemiluminescence detection as previously described (Berson 
et al., 2000). In brief, whole cell lysates prepared by boiling in 1% SDS 
and sonication were fractionated by SDS-PAGE. After electrotransfer to 
polyvinylidene difluoride membranes and blocking in Blotto (PBS/5% milk/ 
0.1% Tween 20), membranes were probed sequentially (with washing in 
between with PBS) with primary antibodies and alkaline phosphatase–
conjugated goat anti–rabbit immunoglobulin antibody, each diluted in 
Blotto. Blots were developed using ECF enhanced chemifluorescence and 
detected using a phosphorimager (Storm 860; Molecular Dynamics) with 
ImageQuant software (GE Healthcare).
Fluorescence microscopy
Standard IFM and colocalization analyses. Cells were plated on Matrigel 
(BD)-coated coverslips, fixed with 2% formaldehyde, labeled with primary 
and secondary antibodies, mounted in Fluoromount-G (SouthernBiotech), 
and analyzed on a microscope (DM IRBE; Leica) equipped with a 63× or 
100× Plan Apochromat objective lens (Leica; both 1.4 NA) and either an 
Orca 100 (Hamamatsu Photonics) or a Retiga EXi Fast 1394 (QImaging) 
digital camera as described previously (Setty et al., 2007). Images in se-
quential z planes were captured, deconvolved, analyzed, and manipulated 
using OpenLab (PerkinElmer) software and subtractive volume deconvolu-
tion. Quantification of the area of overlap in the cell periphery between 
markers in double labeling experiments was performed as described previ-
ously (Setty et al., 2007). In brief, deconvolved single-plane images of 
cells (captured at 63×) labeled for each marker in ≥10 cell profiles for each 
comparison were rendered binary by density slicing using OpenLab soft-
ware; the intensely labeled perinuclear region was excluded; the total la-
beled area in each channel was calculated for objects larger than 5 pixels; 
an overlap image was calculated using the “AND” function, and the total 
area of overlap was calculated for objects larger than 5 pixels; and the 
percentage of overlap was defined as the total area of overlap divided by 
the total area labeled in the reference channel. Quantification of the area 
of overlap in the cell periphery between TYR and pigmented melanosomes 
was carried out using ImageJ (http://fiji.sc/Fiji; National Institutes of Health) 
on wide-field fluorescence images acquired at 63×. In brief, binary images 
of fluorescence (TYR labeling) were generated by subtracting the local back-
ground before thresholding using parameters of a rolling ball radius of 10 
pixels with smoothing disabled, and binary images of pigment granules 
from bright-field imaging were generated by manual thresholding. The Image 
Calculator function was used to multiply the binary images for bright-field 
melanosomes and TYR staining; the resulting image represents the area of 
overlap between TYR staining and melanosomes. The areas of overlap and 
of total TYR labeling in structures larger than 5 pixels were quantified using 
the Analyze Particles function; the ratio of overlap pixels to total TYR pixels 
gives the percentage of overlap.
TYRP1 depletion from the Golgi. WT melan-Ink4a and BLOC-2 melano-
cytes plated on Matrigel-coated coverslips 24 h earlier were incubated with 
300 µg/ml CHX at 37°C for the indicated times. Cells were then fixed by 
addition of an equal volume of 6% paraformaldehyde in HBSS and pro-
cessed for IFM analysis as described under Standard IFM and colocalization 
analyses using a 40× Neofluor objective lens. TYRP1 fluorescence intensity 
within a masked region identified by giantin labeling was quantified using 
Volocity software (PerkinElmer). Images shown in Fig. 5 were captured as 
described for colocalization analyses.
FRAP. WT and BLOC-2 cells were plated on Matrigel-coated 35-mm 
glass-bottom dishes (MatTek Corporation) and transiently transfected to ex-
press TYRP1-EGFP and GM130-mCh. 24 h after transfection, cells were 
pretreated with 300 µg/ml CHX in culture medium at 37°C for 60 min and 
imaged using a spinning-disk confocal microscope (UltraVIEW; PerkinElmer) 
equipped with a 63× Plan Apochromat lens (Carl Zeiss), a camera (Orca-
ER; Hamamatsu Photonics), an environmental chamber kept at 37°C, and 
Volocity software (PerkinElmer). Images were captured at 1 frame per sec-
ond (fps) for 2 min and an additional 3 min at 1 frame per 5 s. At frame 5 
(corresponding to 5 s of imaging), a region defined as GM130-mCh posi-
tive was bleached for GFP with a PhotoKinesis device (PerkinElmer). Fluor-
escence intensity of TYRP1-EGFP was quantified using ImageJ and 
normalized to mean prebleach GFP intensity within the bleached region 
and corrected for loss of fluorescence in an unbleached region.
CTxB retrograde trafficking. For CTxB uptake, WT, BLOC-2, BLOC-2R, 
BLOC-2C, melan-ru, or melan-ru:HPS6 cells plated on Matrigel-coated cover-
slips 24 h earlier were incubated on ice for 1 h with AF488-conjugated CTxB 
(2 mg/ml; Sigma Aldrich) in complete medium. Cells were then warmed to 
20°C for 15 min to allow internalization, and then washed three times with 
ice cold medium and incubated for 15–240 min at 37°C. Cells were pro-
cessed for IFM analysis as described for TYRP1 Golgi depletion.
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